PTK2 and osteosarcoma: A previous study also showed that inhibition of FAK expression by siRNA pronouncedly induced apoptosis of osteosarcoma cells in p53- and caspase-dependent manners and enhanced additive cytotoxic effect when combined with chemotherapy treatment, supporting FAK function as a potent inhibitor of apoptosis as well as an attractive therapeutic target in osteosarcoma [41].